Page last updated: 2024-11-01

nipecotic acid and Huntington Disease

nipecotic acid has been researched along with Huntington Disease in 1 studies

nipecotic acid: RN given refers to cpd without isomeric designation
nipecotic acid : A piperidinemonocarboxylic acid that is piperidine in which one of the hydrogens at position 3 is substituted by a carboxylic acid group.

Huntington Disease: A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)

Research Excerpts

ExcerptRelevanceReference
"Putamen tissue from four cases of Huntington's disease showed a marked reduction in [3H]nipecotic acid binding."1.28[3H]nipecotic acid binding to gamma-aminobutyric acid uptake sites in postmortem human brain. ( Czudek, C; Reynolds, GP, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Czudek, C1
Reynolds, GP1

Other Studies

1 other study available for nipecotic acid and Huntington Disease

ArticleYear
[3H]nipecotic acid binding to gamma-aminobutyric acid uptake sites in postmortem human brain.
    Journal of neurochemistry, 1990, Volume: 55, Issue:1

    Topics: Aged; Aging; Binding Sites; Brain; Cadaver; Female; gamma-Aminobutyric Acid; Hippocampus; Humans; Hu

1990